Key Takeaways
- • The UK government's £1 billion scale-up fund faces industry backlash over potential management by traditional asset managers M&G and Schroders rather than specialist venture capital firms, with leading VC investors warning this would compromise deal access and returns.
- • Prominent early-stage investors—including founders of backers to British unicorns Elevenlabs, Synthesia, and Fuse Energy—argue that awarding the mandate to a general institutional investment house would "make a mockery" of the UK venture ecosystem and exclude the fund from access to top-tier growth companies.
- • Alex Macdonald, chief executive of seed-stage investor Sequel, has called for the government to select a "proven venture investment manager" with demonstrated ecosystem credibility and technology sector expertise over a public markets-focused competitor.
- • The £1 billion fund, launched with backing from a consortium of pension providers, is positioned as critical infrastructure to connect institutional capital with UK science and technology companies driving innovation, but industry skeptics question whether non-specialist management can effectively execute this mandate.
Summary
The UK government's flagship £1 billion scale-up fund has ignited a firestorm within the venture capital industry following revelations that major traditional asset managers M&G and Schroders have submitted bids to manage the investment vehicle. Leading venture capitalists have issued stark warnings that awarding the mandate to a generalist institutional investment house rather than a specialist growth equity firm would undermine fund performance, alienate deal flow, and damage the credibility of Britain's venture ecosystem.
The criticism centers on a fundamental mismatch between investment management philosophy and operational execution. Venture heavyweights—many of whom are early backers of notable British unicorns including Elevenlabs, Synthesia, and Fuse Energy—argue that scale-up investing requires deep sector expertise, established relationships within the startup ecosystem, and demonstrated technology sector acumen that generalist asset managers typically lack. Alex Macdonald, chief executive of seed-stage investment firm Sequel, articulated the industry position bluntly, stating that selecting a traditional public markets investor over a growth investing specialist would "make a mockery of the venture industry in the UK." Macdonald emphasized that government should entrust the mandate to "a proven venture investment manager" with "credibility, understands the space and understands technology."
The fund was launched last month with backing from a pension provider consortium and is explicitly designed to invest across science and technology companies, positioning institutional capital alongside entrepreneurs driving the next generation of British innovation. However, the controversy reflects structural tensions in how large-scale venture funding is deployed—whether specialized venture firms or diversified asset managers are better equipped to identify, execute, and scale early-stage technology investments at the £1 billion institutional scale required by this mandate.
The criticism centers on a fundamental mismatch between investment management philosophy and operational execution. Venture heavyweights—many of whom are early backers of notable British unicorns including Elevenlabs, Synthesia, and Fuse Energy—argue that scale-up investing requires deep sector expertise, established relationships within the startup ecosystem, and demonstrated technology sector acumen that generalist asset managers typically lack. Alex Macdonald, chief executive of seed-stage investment firm Sequel, articulated the industry position bluntly, stating that selecting a traditional public markets investor over a growth investing specialist would "make a mockery of the venture industry in the UK." Macdonald emphasized that government should entrust the mandate to "a proven venture investment manager" with "credibility, understands the space and understands technology."
The fund was launched last month with backing from a pension provider consortium and is explicitly designed to invest across science and technology companies, positioning institutional capital alongside entrepreneurs driving the next generation of British innovation. However, the controversy reflects structural tensions in how large-scale venture funding is deployed—whether specialized venture firms or diversified asset managers are better equipped to identify, execute, and scale early-stage technology investments at the £1 billion institutional scale required by this mandate.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.